語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
The Effect of Audit Committee Attrib...
~
Gaetani, Melisa Emily.
FindBook
Google Book
Amazon
博客來
The Effect of Audit Committee Attributes on Financial Statement Restatements in the Pharmaceutical Industry.
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
The Effect of Audit Committee Attributes on Financial Statement Restatements in the Pharmaceutical Industry./
作者:
Gaetani, Melisa Emily.
出版者:
Ann Arbor : ProQuest Dissertations & Theses, : 2018,
面頁冊數:
123 p.
附註:
Source: Dissertation Abstracts International, Volume: 80-01(E), Section: A.
Contained By:
Dissertation Abstracts International80-01A(E).
標題:
Accounting. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10928896
ISBN:
9780438308992
The Effect of Audit Committee Attributes on Financial Statement Restatements in the Pharmaceutical Industry.
Gaetani, Melisa Emily.
The Effect of Audit Committee Attributes on Financial Statement Restatements in the Pharmaceutical Industry.
- Ann Arbor : ProQuest Dissertations & Theses, 2018 - 123 p.
Source: Dissertation Abstracts International, Volume: 80-01(E), Section: A.
Thesis (D.B.A.)--Northcentral University, 2018.
Financial statement restatements signal to stakeholders that the reported financial information can no longer be relied upon; therefore, it must be restated in order to be reliably utilized for decision-making. In response to the catastrophic financial reporting scandals in the early 2000s, the Sarbanes-Oxley Act of 2002 ("SOX") was enacted to protect the pubic by prescribing precautionary and accountability measures for those charged with financial reporting governance. The audit committee, a subcommittee of the board of directors, was one of the main financial reporting stewards targeted by SOX. The problem addressed by the research is that a lack of quality on the audit committee can result in restatements for U.S. publicly-traded pharmaceutical companies. Using agency and positive accounting theory as guiding frameworks, the purpose of the study was to investigate the relationship between audit committee quality and the presence and/or severity of restatements. The study developed a definition of audit committee quality by using the minimum audit committee requirements set out in SOX as a foundation. Subsequently, existing academic literature was turned to in order to develop and refine a scoring system to quantify the audit committee quality variable. The study was conducted quantitatively using a correlational analysis between the independent variable, audit committee quality, and the dependent variable, restatement severity. The population examined was pharmaceutical companies listed on the NYSE or NASDAQ during the period of 2015--016. Out of a total population of 2,104 filings, data from a sample of 134 filings was hand-collected from publicly available databases. A correlational analysis found a moderate negative correlation between audit committee quality and restatement severity (r = --.4733). The results of the study are important to academics and practitioners alike given the establishment of a theoretical model upon which future studies can be developed as well as metrics to select and evaluate audit committees.
ISBN: 9780438308992Subjects--Topical Terms:
557516
Accounting.
The Effect of Audit Committee Attributes on Financial Statement Restatements in the Pharmaceutical Industry.
LDR
:03049nmm a2200301 4500
001
2203976
005
20190624102616.5
008
201008s2018 ||||||||||||||||| ||eng d
020
$a
9780438308992
035
$a
(MiAaPQ)AAI10928896
035
$a
(MiAaPQ)northcentral:13219
035
$a
AAI10928896
040
$a
MiAaPQ
$c
MiAaPQ
100
1
$a
Gaetani, Melisa Emily.
$3
3430791
245
1 4
$a
The Effect of Audit Committee Attributes on Financial Statement Restatements in the Pharmaceutical Industry.
260
1
$a
Ann Arbor :
$b
ProQuest Dissertations & Theses,
$c
2018
300
$a
123 p.
500
$a
Source: Dissertation Abstracts International, Volume: 80-01(E), Section: A.
500
$a
Adviser: Charles Fenner.
502
$a
Thesis (D.B.A.)--Northcentral University, 2018.
520
$a
Financial statement restatements signal to stakeholders that the reported financial information can no longer be relied upon; therefore, it must be restated in order to be reliably utilized for decision-making. In response to the catastrophic financial reporting scandals in the early 2000s, the Sarbanes-Oxley Act of 2002 ("SOX") was enacted to protect the pubic by prescribing precautionary and accountability measures for those charged with financial reporting governance. The audit committee, a subcommittee of the board of directors, was one of the main financial reporting stewards targeted by SOX. The problem addressed by the research is that a lack of quality on the audit committee can result in restatements for U.S. publicly-traded pharmaceutical companies. Using agency and positive accounting theory as guiding frameworks, the purpose of the study was to investigate the relationship between audit committee quality and the presence and/or severity of restatements. The study developed a definition of audit committee quality by using the minimum audit committee requirements set out in SOX as a foundation. Subsequently, existing academic literature was turned to in order to develop and refine a scoring system to quantify the audit committee quality variable. The study was conducted quantitatively using a correlational analysis between the independent variable, audit committee quality, and the dependent variable, restatement severity. The population examined was pharmaceutical companies listed on the NYSE or NASDAQ during the period of 2015--016. Out of a total population of 2,104 filings, data from a sample of 134 filings was hand-collected from publicly available databases. A correlational analysis found a moderate negative correlation between audit committee quality and restatement severity (r = --.4733). The results of the study are important to academics and practitioners alike given the establishment of a theoretical model upon which future studies can be developed as well as metrics to select and evaluate audit committees.
590
$a
School code: 1443.
650
4
$a
Accounting.
$3
557516
650
4
$a
Pharmaceutical sciences.
$3
3173021
690
$a
0272
690
$a
0572
710
2
$a
Northcentral University.
$b
Business and Technology Management.
$3
2100236
773
0
$t
Dissertation Abstracts International
$g
80-01A(E).
790
$a
1443
791
$a
D.B.A.
792
$a
2018
793
$a
English
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10928896
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9380525
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入